Quality and value are two important drivers of stock market returns - yet many investors fail to take them seriously. At a time of economic uncertainty, using these two powerful factors to find stocks could help you navigate market vol...
CNC — Centene Share Price
0.000.00%
Last trade - 00:00HealthcareBalancedLarge CapSuper Stock
- $47.90bn
- $55.85bn
- $125.98bn
- 56
- 81
- 99
- 90
Momentum
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | 14.68 | ||
| PEG Ratio (f) | 28.1 | ||
| EPS Growth (f) | 0.53% | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 1.84 | ||
| Price to Tang. Book | n/a | ||
| Price to Free Cashflow | 11.48 | ||
| Price to Sales | 0.37 | ||
| EV to EBITDA | 15.29 | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | 2.75% | ||
| Return on Equity | 5.6% | ||
| Operating Margin | 1.71% | ||
Financial Summary
| Year End 31st Dec | Unit | 2017 | 2018 | 2019 | 2020 | 2021 | 2022E | 2023E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | $m | 48,382 | 60,116 | 74,639 | 111,115 | 125,982 | 141,532.48 | 141,484.02 | 25.41% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | +28.3 | +34.84 | +56.33 | +22.9 | +5.43 | -7.98 | +14.39 | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Health Trend(F-Score)
12345678910
Bankruptcy Score(Z-Score)
Distress
Cautious
Safe
Earnings Manipulation Risk(M-Score)
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Latest News & Insights for CNC
Quality and value are two important drivers of stock market returns - yet many investors fail to take them seriously. At a time of economic uncertainty, using these two powerful factors to find stocks could help you navigate market vol...
Research shows that quality and value are two powerful drivers of stock market profits. After the economic turmoil we've seen over the past year, it's possible that these two factors could have an influence on the Centene (NYQ:CNC) sha...
Quality and value are two important drivers of stock market returns - yet many investors fail to take them seriously. At a time of economic uncertainty, using these two powerful factors to find stocks could help you navigate market vol...
Shares in Centene (NYQ:CNC) are currently trading at 61.03 but a key question for investors is how the economic uncertainty caused by Covid-19 will affect the price. Part of the answer comes down to judging whether the stock is well pl...
Profile Summary
Centene Corporation is a multi-national healthcare company. The Company provides services to government-sponsored and commercial healthcare programs, focusing on under-insured and uninsured individuals. It also provides education and outreach programs to inform and assist members in accessing appropriate healthcare services. Its segments include Managed Care and Specialty Services. The Managed Care segment provides health plan coverage to individuals through government subsidized and commercial programs. Its Specialty Services segment includes companies offering diversified healthcare services and products to its Managed Care segment and other external customers. It provides managed healthcare products and services through Medicaid, Medicare and commercial products. In addition to its Medicaid and Medicare services, its service offerings include commercial programs, correctional healthcare services, government-sponsored care under federal contracts with the department of defense (DoD).
Directors
- Michael Neidorff CHM (78)
- Brent Layton PRE (54)
- Sarah London VCH (41)
- Andrew Asher CFO (52)
- Shannon Bagley EVP
- Mark Brooks EVP (51)
- H. Robert Sanders EVP
- Brandy Burkhalter EVP (48)
- Colin Toney EVP
- Suzy DePrizio SVP
- Katie Casso SVP
- Rich Fisher SVP
- Jim Murray OTH
- Christopher Koster SEC (56)
- H. James Dallas LED (62)
- Orlando Ayala IND (64)
- Jessica Blume IND (66)
- Robert Ditmore IND (87)
- Frederick Eppinger IND (62)
- Richard Gephardt IND (80)
- Leslie Norwalk IND (55)
- John Roberts IND (79)
- Lori Robinson IND (62)
- Thomas Thompson IND (79)
- William Trubeck IND (74)
- Last Annual
- December 31st, 2021
- Last Interim
- March 31st, 2022
- Incorporated
- September 26th, 2001
- Public Since
- December 13th, 2001
- No. of Shareholders
- 1,078
- No. of Employees
- 72,500
- Sector
- Healthcare Providers & Services
- Industry
- Healthcare
- Exchange
- New York Stock Exchange
- Shares in Issue
- 584,886,987
- Address
- 7700 Forsyth Blvd, ST. LOUIS, 63105-1807
- Web
- https://www.centene.com/
- Phone
- +1 3147254477
- Auditors
- KPMG LLP
Latest News for CNC
Upcoming Events for CNC
Centene Corp Investor Meeting (Virtual)
Q2 2022 Centene Corp Earnings Release
Q3 2022 Centene Corp Earnings Release
Similar to CNC
Agilon Health
New York Stock Exchange
AMERICAN WELL
New York Stock Exchange
AMN Healthcare Services
New York Stock Exchange
Anthem
New York Stock Exchange
Ardent Health Partners LLC
New York Stock Exchange
FAQ
What is the Centene share price?
As of Today at 13:05 UTC, shares in Centene are trading at $85.31. This share price information is delayed by 15 minutes.
How has the Centene share price performed this year?
Shares in Centene last closed at $85.31 and the price had moved by +15.35% over the past 365 days. In terms of relative price strength the Centene share price has outperformed the S&P500 Index by +21.64% over the past year.
What are the analyst and broker recommendations for Centene?
The overall consensus recommendation for Centene is Buy. You can view the full broker recommendation list by unlocking its StockReport.
What is the Centene dividend yield?
Centene does not currently pay a dividend.
Does Centene pay a dividend?
Centene does not currently pay a dividend.
When does Centene next pay dividends?
Centene does not currently pay a dividend.
How do I buy Centene shares?
To buy shares in Centene you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of Centene?
As of the previous close price of $85.31, shares in Centene had a market capitalisation of $47.90bn.
Where are Centene shares listed?
Here are the trading details for Centene:
- Country of listing: United States
- Exchange: NYQ
- Ticker Symbol: CNC
What kind of share is Centene?
Based on an overall assessment of its quality, value and momentum Centene is currently classified as a Super Stock. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a Centene share price forecast for 2022?
The analyst consensus target price for shares in Centene is $99.43. That is 16.55% above the last closing price of $85.31.
Analysts covering Centene currently have a consensus Earnings Per Share (EPS) forecast of $5.50 for the next financial year.
What is the trend in the Centene share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Centene. Over the past six months, its share price has outperformed the S&P500 Index by +35.07%.
As of the last closing price of $85.31, shares in Centene were trading +11.88% higher than their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the Centene PE Ratio?
The Centene PE ratio based on its reported earnings over the past 12 months is 14.68. The shares last closed at $85.31.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of Centene?
Centene's management team is headed by:
- Michael Neidorff - CHM
- Brent Layton - PRE
- Sarah London - VCH
- Andrew Asher - CFO
- Shannon Bagley - EVP
- Mark Brooks - EVP
- H. Robert Sanders - EVP
- Brandy Burkhalter - EVP
- Colin Toney - EVP
- Suzy DePrizio - SVP
- Katie Casso - SVP
- Rich Fisher - SVP
- Jim Murray - OTH
- Christopher Koster - SEC
- H. James Dallas - LED
- Orlando Ayala - IND
- Jessica Blume - IND
- Robert Ditmore - IND
- Frederick Eppinger - IND
- Richard Gephardt - IND
- Leslie Norwalk - IND
- John Roberts - IND
- Lori Robinson - IND
- Thomas Thompson - IND
- William Trubeck - IND